Patents by Inventor Evanthia GALANIS

Evanthia GALANIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MATERIALS AND METHODS FOR TREATING CANCER
    Publication number: 20240165178
    Abstract: This document relates to materials and methods involved in treating cancer. For example, materials and methods for using one or more oncolytic viruses (e.g., one or more oncolytic viruses) to treat cancer in a mammal (e.g., a human) identified as having a cancer likely to respond to oncolytic virotherapy are provided.
    Type: Application
    Filed: November 28, 2023
    Publication date: May 23, 2024
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Evanthia Galanis, S. Keith Anderson, Cheyne B. Kurokawa, Ianko D. Iankov
  • Materials and methods for treating cancer
    Patent number: 11865150
    Abstract: This document provides methods and materials involved in treating cancer. For example, methods and materials for using an inhibitor of UFM1 activity or expression and/or an inhibitor of UFL1 activity or expression to reduce a cancer cell's ability to carry out a DDR, thereby increasing the sensitivity of cancer cells to treatment with a DNA damaging therapy such as radiation or chemotherapy, are provided.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: January 9, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Evanthia Galanis, S. Keith Anderson, Cheyne B. Kurokawa, Ianko D. Iankov
  • MATERIALS AND METHODS FOR TREATING CANCER
    Publication number: 20190365836
    Abstract: This document provides methods and materials involved in treating cancer. For example, methods and materials for using an inhibitor of UFM1 activity or expression and/or an inhibitor of UFL1 activity or expression to reduce a cancer cell's ability to carry out a DDR, thereby increasing the sensitivity of cancer cells to treatment with a DNA damaging therapy such as radiation or chemotherapy, are provided.
    Type: Application
    Filed: January 11, 2018
    Publication date: December 5, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Evanthia GALANIS, S. Keith ANDERSON, Cheyne B. KUROKAWA, Ianko D. IANKOV